ChromaDex’s Dr Charles Brenner talks NAD+ and
Author: Michael
A global gathering for thought leaders in longev
Our 2024 Longevity Clinics Survey is open with r
Mutual funds and top VCs back biopharma with cli
New funding positions biotech to expand research
Initial product is a longevity supplement design
Rubedo’s new CEO discusses the potential for s
Genesis to work with NVIDIA to optimize its neur
Supporting earlier and more precise detection, C
Developed using generative AI for treatment of I